Reproducibility 1 Reproducibility in Clinical Psychology Christopher J

Total Page:16

File Type:pdf, Size:1020Kb

Reproducibility 1 Reproducibility in Clinical Psychology Christopher J Reproducibility 1 Reproducibility in Clinical Psychology Christopher J. Hopwood and Simine Vazire University of California, Davis For: A.G.C. Wright and M.N. Hallquist Handbook of Research Methods in Clinical Psychology Reproducibility 2 There is a long history of invalid ideas in clinical psychology, many of which have had profound negative effects on public health and individual lives. “Refrigerator mothers” were once blamed for autism (Greydnaus & Toledo-Pereya, 2012). Leeching (De Young, 2015), animal magnetism (Ellenberger, 1970), and the orgone box (Isaacs, 1999) were once proposed to treat mental illness. In each of these cases and many others, invalid ideas were corrected by scientific research, to the benefit of the public interest. The ability to identify and correct bad ideas about etiology and intervention is the primary virtue of a scientific approach to clinical psychology. Although the causes of psychopathology or the best way to prevent and treat problems in living remain poorly understood, there has been clear progress in the field that can be attributed directly to the scientific method. Invalid and harmful theories are not isolated to the distant past. In 1998, Wakefield and colleagues published a paper in a prestigious journal ostensibly linking the measles, mumphs, and rubella (MMR) vaccine to autism. Although it was based on a small sample of only 12 children, the finding was highly publicized. Even though a number of epidemiological studies found no association between the MMR vaccine and autism, rates of MMR vaccinations decreased and rates of measles, mumphs, and rubella increased in the United Kingdom following the publication of the study (McIntyre & Leask, 2008). After journalists uncovered multiple conflicts of interest, questionable research practices, and several ethical violations, the journal retracted the paper. Wakefield had apparently reported fraudulent data after having been paid to “find” a link between the MMR vaccine and autism (Godlee, 2011). He was found guilty of malpractice and lost his medical license in the United Kingdom. Since the time of the Wakefield et al. study there has been a crescendo of high profile false positives in the psychology literature (e.g., Klein et al., 2014). The issue has been widely discussed in the scientific literature (Baker, 2016; Nosek, 2012), the blogosphere (e.g., Gelman, 2016; Srivastava, 2016; Vazire, 2016), and the popular press (Aschwanden, 2015; Belluz, 2015; Engber, 2016; Yong, 2016). This is a serious problem. Faulty science in clinical psychology negatively affects patients and the public Reproducibility 3 because unhelpful or harmful practices are disseminated to ill effect and because persistent reports of invalid findings in the popular press can erode public trust in the scientific method. But it is also a fortuitous opportunity to improve clinical psychological research (Munafo et al., 2017; Tackett et al., in press). An upshot of recent discoveries of invalid findings has been a movement dedicated to teaching and disseminating more rigorous scientific methods (e.g., Open Science Collaboration, 2015). A central focus of this movement has involved investigating the reproducibility of reported effects. Genuine effects should be reproducible, and effects that cannot be reproduced should generally not be taken to be true. The purposes of this chapter are to describe the importance of reproducibility in the scientific method, review recent issues in the social sciences that contributed to the recognition of reproducibility problems, and describe best practices for conducting reproducible research in clinical psychology. Foundations of the Scientific Method The scientific method is one way of explaining phenomena. It can be contrasted with other methods, such as explanation via tradition or metaphysics, by a few foundational principles. In this section, we briefly review the distinguishing principles of the scientific method, with a focus on reproducibility. Observations and Explanations For an explanation of a phenomenon to be convincing in a scientific sense, it must explain and predict observations (Hempel & Oppenheim, 1948). Thus, science is fundamentally about the link between observations in nature and explanations about why those observations occurred. When explanations predict the same observations more than once they are increasingly convincing, and when they can predict similar kinds of observations across different contexts and situations, they become increasingly general. Reproducibility 4 Unlike in most other approaches to knowing, science rests on the principle of falsification (Popper, 1950), or the idea that scientists try to prove their explanations wrong rather than trying to prove them right. It follows from the idea of falsification that observations that are consistent with an explanation add confidence for that explanation but do not prove that it is true, whereas observations that are inconsistent with an explanation indicate that the explanation is at least partly inaccurate. This makes science really difficult, because our interest generally lies in proving something to be true rather than incrementally increasing our confidence that our explanation probably isn’t wrong. And as a general rule, it is easy to fool ourselves, particularly when we are motivated to see things a certain way (Feynman & Leighton, 1988). Replication This is why replication is so important in science. Replication means making the same explanation-relevant observations more than once in order to test the validity of the explanation. There are different levels of replication, ranging from completely direct to completely conceptual or constructive (Lykken, 1968). In the most direct replication, an observation would be sampled twice by the same person under maximally similar conditions. A replication becomes less direct when the same observations are made under highly similar conditions but by different people. This increases confidence in the observation. For instance, if you told your friend that you had blown up a plastic bottle by pouring vinegar and baking soda into it, she might be skeptical. If she saw it on video, her confidence would increase. If she did it herself, she would probably be basically convinced. Conceptual replications push the boundaries of the explanation by changing the conditions of the experiment. If you knew that mixing vinegar (an acid) and baking soda (a base) together creates a reaction that produces carbon dioxide, and you knew that carbon dioxide is less dense than regular air, it would follow that mixing vinegar and baking soda together in a plastic bottle would expand the bottle until it burst. Other things would follow, too. For instance, this should also work in closed spaces other Reproducibility 5 than a plastic bottle, and it should also work with other acid-base combinations. The underlying explanation for why the bottle blew up when vinegar was added to baking soda provides a basis for setting up conceptual replications that could test that explanation further and evaluate the boundary conditions of the effect. To use a more clinical example, it is probable that an astute physician observed many years ago that psychotic patients had an unusually high incidence of family members with mental health problems. Having shared this observation with his colleagues, others may have made similar observations. Eventually, early psychiatrists tested the concordance rates of family members in a controlled manner and confirmed an association, even across multiple ways of assessing psychotic conditions and evaluating family concordance (e.g., Jelliffe, 1911). This important set of observations could be used to support multiple possible explanations, including those related to heritability, the problematic “refrigerator mother” hypothesis, and others. These explanations were eventually tested as well, leading to the contemporary understanding that the increased incidence of psychotic symptoms among family members is most likely genetically mediated (Gottesman & Shields, 1973). While the etiology of psychotic phenomena remains poorly understood, replicated research on familial concordance that can be explained by nature to a greater degree than nurture advances our understanding significantly. From a scientific perspective, this kind of replicated evidence is always more convincing than any well-crafted argument untethered to replicated observations. Both direct and conceptual replication are important, for different reasons. Conceptual replications are a riskier test of a theory, extrapolating from past findings to make new predictions (e.g., predicting the effect in a new setting, population, or using a different measure). However, ifa conceptual replication fails, this result is ambiguous. It could mean that the original theory was wrong, and even the early successful studies should be discounted as evidence for the theory, or it could mean that the researcher extrapolated one step too far, but the earlier successful studies should still be taken Reproducibility 6 as strong evidence in support of the theory. Direct replications are useful because they eliminate this ambiguity. If all attempts to directly replicate a finding fail, this suggests that the original finding should not be taken as evidence for the theory, and that the theory is likely wrong. Thus, from a falsification perspective, direct replications are stronger tests because they expose the researcher to the risk of being forced to abandon their theory.
Recommended publications
  • Reproducibility, Replicability, and Generalization in the Social, Behavioral, and Economic Sciences
    REPRODUCIBILITY, REPLICABILITY, AND GENERALIZATION IN THE SOCIAL, BEHAVIORAL, AND ECONOMIC SCIENCES Report of the Subcommittee on Replicability in Science of the SBE Advisory Committee to the National Science Foundation 13 May 2015 Presentation at SBE AC Spring Meeting by K. Bollen. Report of the Subcommittee on Replicability in Science Advisory Committee to the NSF SBE Directorate Subcommittee Members: Kenneth Bollen (University of North Carolina at Chapel Hill, Cochair) John T. Cacioppo (University of Chicago, Cochair) Robert M. Kaplan (Agency for Healthcare Research and Quality) Jon A. Krosnick (Stanford University) James L. Olds (George Mason University) Staff Assistance Heather Dean (National Science Foundation) TOPICS I. Background II. Subcommittee Report III. Definitions IV. Recommendations V. Final Comments Background • Spring, 2013 o NSF SBE Advisory Committee establishes subcommittee on how SBE can promote robust research practices • Summer & Fall 2013 o Subcommittee proposal for workshop on “Robust Research in the Social, Behavioral, and Economic Sciences.” • February 20-21, 2014 o Workshop convened o Participants drawn from variety of universities, funding agencies, scientific associations, and journals o Cover broad range of issues from extent and cause of problems to possible solutions o Details are in the appendix of the circulated report • Post-workshop period o Document & digest workshop content o Discuss and propose recommendations o Complete report Subcommittee Report • DEFINITIONS o No consensus in science on the meanings
    [Show full text]
  • FDA Oncology Experience in Innovative Adaptive Trial Designs
    Innovative Adaptive Trial Designs Rajeshwari Sridhara, Ph.D. Director, Division of Biometrics V Office of Biostatistics, CDER, FDA 9/3/2015 Sridhara - Ovarian cancer workshop 1 Fixed Sample Designs • Patient population, disease assessments, treatment, sample size, hypothesis to be tested, primary outcome measure - all fixed • No change in the design features during the study Adaptive Designs • A study that includes a prospectively planned opportunity for modification of one or more specified aspects of the study design and hypotheses based on analysis of data (interim data) from subjects in the study 9/3/2015 Sridhara - Ovarian cancer workshop 2 Bayesian Designs • In the Bayesian paradigm, the parameter measuring treatment effect is regarded as a random variable • Bayesian inference is based on the posterior distribution (Bayes’ Rule – updated based on observed data) – Outcome adaptive • By definition adaptive design 9/3/2015 Sridhara - Ovarian cancer workshop 3 Adaptive Designs (Frequentist or Bayesian) • Allows for planned design modifications • Modifications based on data accrued in the trial up to the interim time • Unblinded or blinded interim results • Control probability of false positive rate for multiple options • Control operational bias • Assumes independent increments of information 9/3/2015 Sridhara - Ovarian cancer workshop 4 Enrichment Designs – Prognostic or Predictive • Untargeted or All comers design: – post-hoc enrichment, prospective-retrospective designs – Marker evaluation after randomization (example: KRAS in cetuximab
    [Show full text]
  • FORMULAS from EPIDEMIOLOGY KEPT SIMPLE (3E) Chapter 3: Epidemiologic Measures
    FORMULAS FROM EPIDEMIOLOGY KEPT SIMPLE (3e) Chapter 3: Epidemiologic Measures Basic epidemiologic measures used to quantify: • frequency of occurrence • the effect of an exposure • the potential impact of an intervention. Epidemiologic Measures Measures of disease Measures of Measures of potential frequency association impact (“Measures of Effect”) Incidence Prevalence Absolute measures of Relative measures of Attributable Fraction Attributable Fraction effect effect in exposed cases in the Population Incidence proportion Incidence rate Risk difference Risk Ratio (Cumulative (incidence density, (Incidence proportion (Incidence Incidence, Incidence hazard rate, person- difference) Proportion Ratio) Risk) time rate) Incidence odds Rate Difference Rate Ratio (Incidence density (Incidence density difference) ratio) Prevalence Odds Ratio Difference Macintosh HD:Users:buddygerstman:Dropbox:eks:formula_sheet.doc Page 1 of 7 3.1 Measures of Disease Frequency No. of onsets Incidence Proportion = No. at risk at beginning of follow-up • Also called risk, average risk, and cumulative incidence. • Can be measured in cohorts (closed populations) only. • Requires follow-up of individuals. No. of onsets Incidence Rate = ∑person-time • Also called incidence density and average hazard. • When disease is rare (incidence proportion < 5%), incidence rate ≈ incidence proportion. • In cohorts (closed populations), it is best to sum individual person-time longitudinally. It can also be estimated as Σperson-time ≈ (average population size) × (duration of follow-up). Actuarial adjustments may be needed when the disease outcome is not rare. • In an open populations, Σperson-time ≈ (average population size) × (duration of follow-up). Examples of incidence rates in open populations include: births Crude birth rate (per m) = × m mid-year population size deaths Crude mortality rate (per m) = × m mid-year population size deaths < 1 year of age Infant mortality rate (per m) = × m live births No.
    [Show full text]
  • Incidence and Secondary Transmission of SARS-Cov-2 Infections in Schools
    Prepublication Release Incidence and Secondary Transmission of SARS-CoV-2 Infections in Schools Kanecia O. Zimmerman, MD; Ibukunoluwa C. Akinboyo, MD; M. Alan Brookhart, PhD; Angelique E. Boutzoukas, MD; Kathleen McGann, MD; Michael J. Smith, MD, MSCE; Gabriela Maradiaga Panayotti, MD; Sarah C. Armstrong, MD; Helen Bristow, MPH; Donna Parker, MPH; Sabrina Zadrozny, PhD; David J. Weber, MD, MPH; Daniel K. Benjamin, Jr., MD, PhD; for The ABC Science Collaborative DOI: 10.1542/peds.2020-048090 Journal: Pediatrics Article Type: Regular Article Citation: Zimmerman KO, Akinboyo IC, Brookhart A, et al. Incidence and secondary transmission of SARS-CoV-2 infections in schools. Pediatrics. 2021; doi: 10.1542/peds.2020- 048090 This is a prepublication version of an article that has undergone peer review and been accepted for publication but is not the final version of record. This paper may be cited using the DOI and date of access. This paper may contain information that has errors in facts, figures, and statements, and will be corrected in the final published version. The journal is providing an early version of this article to expedite access to this information. The American Academy of Pediatrics, the editors, and authors are not responsible for inaccurate information and data described in this version. Downloaded from©2021 www.aappublications.org/news American Academy by of guest Pediatrics on September 27, 2021 Prepublication Release Incidence and Secondary Transmission of SARS-CoV-2 Infections in Schools Kanecia O. Zimmerman, MD1,2,3; Ibukunoluwa C. Akinboyo, MD1,2; M. Alan Brookhart, PhD4; Angelique E. Boutzoukas, MD1,2; Kathleen McGann, MD2; Michael J.
    [Show full text]
  • Estimated HIV Incidence and Prevalence in the United States
    Volume 26, Number 1 Estimated HIV Incidence and Prevalence in the United States, 2015–2019 This issue of the HIV Surveillance Supplemental Report is published by the Division of HIV/AIDS Prevention, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention (CDC), U.S. Department of Health and Human Services, Atlanta, Georgia. Estimates are presented for the incidence and prevalence of HIV infection among adults and adolescents (aged 13 years and older) based on data reported to CDC through December 2020. The HIV Surveillance Supplemental Report is not copyrighted and may be used and reproduced without permission. Citation of the source is, however, appreciated. Suggested citation Centers for Disease Control and Prevention. Estimated HIV incidence and prevalence in the United States, 2015–2019. HIV Surveillance Supplemental Report 2021;26(No. 1). http://www.cdc.gov/ hiv/library/reports/hiv-surveillance.html. Published May 2021. Accessed [date]. On the Web: http://www.cdc.gov/hiv/library/reports/hiv-surveillance.html Confidential information, referrals, and educational material on HIV infection CDC-INFO 1-800-232-4636 (in English, en Español) 1-888-232-6348 (TTY) http://wwwn.cdc.gov/dcs/ContactUs/Form Acknowledgments Publication of this report was made possible by the contributions of the state and territorial health departments and the HIV surveillance programs that provided surveillance data to CDC. This report was prepared by the following staff and contractors of the Division of HIV/AIDS Prevention, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, CDC: Laurie Linley, Anna Satcher Johnson, Ruiguang Song, Sherry Hu, Baohua Wu, H.
    [Show full text]
  • Becoming Autistic: How Do Late Diagnosed Autistic People
    Becoming Autistic: How do Late Diagnosed Autistic People Assigned Female at Birth Understand, Discuss and Create their Gender Identity through the Discourses of Autism? Emily Violet Maddox Submitted in accordance with the requirements for the degree of Master of Philosophy The University of Leeds School of Sociology and Social Policy September 2019 1 Table of Contents ACKNOWLEDGEMENTS ................................................................................................................................... 5 ABSTRACT ....................................................................................................................................................... 6 ABBREVIATIONS ............................................................................................................................................. 7 CHAPTER ONE ................................................................................................................................................. 8 INTRODUCTION .............................................................................................................................................. 8 1.1 RESEARCH OBJECTIVES ........................................................................................................................................ 8 1.2 TERMINOLOGY ................................................................................................................................................ 14 1.3 OUTLINE OF CHAPTERS ....................................................................................................................................
    [Show full text]
  • Understanding Relative Risk, Odds Ratio, and Related Terms: As Simple As It Can Get Chittaranjan Andrade, MD
    Understanding Relative Risk, Odds Ratio, and Related Terms: As Simple as It Can Get Chittaranjan Andrade, MD Each month in his online Introduction column, Dr Andrade Many research papers present findings as odds ratios (ORs) and considers theoretical and relative risks (RRs) as measures of effect size for categorical outcomes. practical ideas in clinical Whereas these and related terms have been well explained in many psychopharmacology articles,1–5 this article presents a version, with examples, that is meant with a view to update the knowledge and skills to be both simple and practical. Readers may note that the explanations of medical practitioners and examples provided apply mostly to randomized controlled trials who treat patients with (RCTs), cohort studies, and case-control studies. Nevertheless, similar psychiatric conditions. principles operate when these concepts are applied in epidemiologic Department of Psychopharmacology, National Institute research. Whereas the terms may be applied slightly differently in of Mental Health and Neurosciences, Bangalore, India different explanatory texts, the general principles are the same. ([email protected]). ABSTRACT Clinical Situation Risk, and related measures of effect size (for Consider a hypothetical RCT in which 76 depressed patients were categorical outcomes) such as relative risks and randomly assigned to receive either venlafaxine (n = 40) or placebo odds ratios, are frequently presented in research (n = 36) for 8 weeks. During the trial, new-onset sexual dysfunction articles. Not all readers know how these statistics was identified in 8 patients treated with venlafaxine and in 3 patients are derived and interpreted, nor are all readers treated with placebo. These results are presented in Table 1.
    [Show full text]
  • The Persistence of Fad Interventions in the Face of Negative Scientific Evidence: Facilitated Communication for Autism As a Case Example
    Evidence-Based Communication Assessment and Intervention ISSN: 1748-9539 (Print) 1748-9547 (Online) Journal homepage: http://www.tandfonline.com/loi/tebc20 The persistence of fad interventions in the face of negative scientific evidence: Facilitated communication for autism as a case example Scott O. Lilienfeld, Julia Marshall, James T. Todd & Howard C. Shane To cite this article: Scott O. Lilienfeld, Julia Marshall, James T. Todd & Howard C. Shane (2014) The persistence of fad interventions in the face of negative scientific evidence: Facilitated communication for autism as a case example, Evidence-Based Communication Assessment and Intervention, 8:2, 62-101, DOI: 10.1080/17489539.2014.976332 To link to this article: http://dx.doi.org/10.1080/17489539.2014.976332 Published online: 02 Feb 2015. Submit your article to this journal Article views: 5252 View related articles View Crossmark data Citing articles: 1 View citing articles Full Terms & Conditions of access and use can be found at http://www.tandfonline.com/action/journalInformation?journalCode=tebc20 Download by: [University of Lethbridge] Date: 05 October 2015, At: 05:52 Evidence-Based Communication Assessment and Intervention, 2014 Vol. 8, No. 2, 62–101, http://dx.doi.org/10.1080/17489539.2014.976332 EBP Advancement Corner The persistence of fad interventions in the face of negative scientific evidence: Facilitated communication for autism as a case example Scott O. Lilienfeld1, Julia Marshall1, James T. Todd2 & Howard C. Shane3 1Department of Psychology, Emory University, Atlanta, GA, USA, 2Department of Psychology, Eastern Michigan University, Ypsilanti, MI, USA, 3Boston Children’s Hospital, Boston, MA, USA ................................................................................................................................................. Abstract Communication disorder and mental health professionals may assume that once novel clinical techniques have been refuted by research, they will be promptly abandoned.
    [Show full text]
  • Rhythm and Timing in Autism: Learning to Dance
    REVIEW ARTICLE published: 19 April 2013 INTEGRATIVE NEUROSCIENCE doi: 10.3389/fnint.2013.00027 Rhythm and timing in autism: learning to dance Pat Amos* Training and Private Consultation, Ardmore, PA, USA Edited by: In recent years, a significant body of research has focused on challenges to neural Anne M. Donnellan, University of connectivity as a key to understanding autism. In contrast to attempts to identify a Wisconsin-Madison, University of single static, primarily brain-based deficit, children and adults diagnosed with autism are San Diego, USA increasingly perceived as out of sync with their internal and external environments in Reviewed by: Elizabeth B. Torres, Rutgers dynamic ways that must also involve operations of the peripheral nervous systems. The University, USA noisiness that seems to occur in both directions of neural flow may help explain challenges Trevor McDonald, Education to movement and sensing, and ultimately to entrainment with circadian rhythms and social Associates Inc., USA interactions across the autism spectrum, profound differences in the rhythm and timing of *Correspondence: movement have been tracked to infancy. Difficulties with self-synchrony inhibit praxis, and Pat Amos, 635 Ardmore Avenue, Ardmore, PA 19003-1831, USA. can disrupt the “dance of relationship” through which caregiver and child build meaning. e-mail: [email protected] Different sensory aspects of a situation may fail to match up; ultimately, intentions and actions themselves may be uncoupled. This uncoupling may help explain the expressions of alienation from the actions of one’s body which recur in the autobiographical autism literature. Multi-modal/cross-modal coordination of different types of sensory information into coherent events may be difficult to achieve because amodal properties (e.g., rhythm and tempo) that help unite perceptions are unreliable.
    [Show full text]
  • Disability in an Age of Environmental Risk by Sarah Gibbons a Thesis
    Disablement, Diversity, Deviation: Disability in an Age of Environmental Risk by Sarah Gibbons A thesis presented to the University of Waterloo in fulfillment of the thesis requirement for the degree of Doctor of Philosophy in English Waterloo, Ontario, Canada, 2016 © Sarah Gibbons 2016 I hereby declare that I am the sole author of this thesis. This is a true copy of the thesis, including any required final revisions, as accepted by my examiners. I understand that my thesis may be made electronically available to the public. ii Abstract This dissertation brings disability studies and postcolonial studies into dialogue with discourse surrounding risk in the environmental humanities. The central question that it investigates is how critics can reframe and reinterpret existing threat registers to accept and celebrate disability and embodied difference without passively accepting the social policies that produce disabling conditions. It examines the literary and rhetorical strategies of contemporary cultural works that one, promote a disability politics that aims for greater recognition of how our environmental surroundings affect human health and ability, but also two, put forward a disability politics that objects to devaluing disabled bodies by stigmatizing them as unnatural. Some of the major works under discussion in this dissertation include Marie Clements’s Burning Vision (2003), Indra Sinha’s Animal’s People (2007), Gerardine Wurzburg’s Wretches & Jabberers (2010) and Corinne Duyvis’s On the Edge of Gone (2016). The first section of this dissertation focuses on disability, illness, industry, and environmental health to consider how critics can discuss disability and environmental health in conjunction without returning to a medical model in which the term ‘disability’ often designates how closely bodies visibly conform or deviate from definitions of the normal body.
    [Show full text]
  • Certification Accredited Schools List
    = Academic Clinical Research Programs Which Currently Meet Waiver Requirements for the Academy of Clinical Research Professional (Updated October 15, 2015) This list includes academic clinical research programs which, as of the above date, have been evaluated and found to meet the current waiver requirements established by the Academy of Clinical Research Professionals (Academy) Board of Trustees. Programs that meet the waiver requirements allow a candidate to waive 1,500 hours of hands-on experience performing the Essential Duties of the program to which the candidate has made application. This list is not to be considered exhaustive and is not designed to represent all the academic offerings available. Appearance on this list is not to be construed as an endorsement of its content or format by the Academy or a guarantee that a candidate will be eligible for certification. All individuals interested in enrolling in a program of study should evaluate any program on the basis of his or her personal needs. (* - programs marked with an asterisk MAY be accepted but acceptance will be dependent on the complete listing of courses completed) Individuals seeking additional information about each program should contact the institution directly. Academic Institution Program Name ( Click Title for Web Navigation) Academy of Applied Pharmaceutical Sciences Clinical Research Diploma Program American University of Health Sciences Master of Science in Clinical Research Anoka-Ramsey Community College Clinical Research Professional - Certificate Graduate
    [Show full text]
  • Placebo-Controlled Trials of New Drugs: Ethical Considerations
    Reviews/Commentaries/Position Statements COMMENTARY Placebo-Controlled Trials of New Drugs: Ethical Considerations DAVID ORENTLICHER, MD, JD als, placebo controls are not appropriate when patients’ health would be placed at significant risk (8–10). A placebo- controlled study for a new hair- uch controversy exists regarding sufficiently more effective than placebo to thickening agent could be justified; a the ethics of placebo-controlled justify its use. Finally, not all established placebo-controlled study for patients M trials in which an experimental therapies have been shown to be superior with moderate or severe hypertension therapy will compete with an already es- to placebo. If newer drugs are compared would not be acceptable (11). Similarly, if tablished treatment (or treatments). In with the unproven existing therapies, an illness causes problems when it goes such cases, argue critics, patients in the then patients may continue to receive untreated for a long period of time, a 52- control arm of the study should receive an drugs that are harmful without being week study with a placebo control is accepted therapy rather than a placebo. helpful. much more difficult to justify than a By using an active and effective drug, the Moreover, say proponents of placebo 6-week study (12). control patients would not be placed at controls, patients can be protected from When David S.H. Bell (13) explains risk for deterioration of their disease, and harm by “escape” criteria, which call for why placebo controls are unacceptable the study would generate more meaning- withdrawal from the trial if the patient for new drugs to treat type 2 diabetes, he ful results for physicians.
    [Show full text]